Allurion Q3 2025 Update: Revenue Drop, FDA Milestones, and $5M Funding Boost
Allurion Technologies reports Q3 earnings, sharp revenue drop, but new FDA milestones and a debt‑free strategy hint at a potential rebound.
2 minutes to read
Allurion Technologies Inc